Optimal management of uncomplicated skin and skin structure infections of the lower extremity
Uncomplicated skin and skin structure infections of the lower extremity are almost always curable when properly diagnosed and promptly treated with antibiotics, but they can cause serious complications if not treated appropriately. These infections are caused often by Staphylococcus aureus and less commonly by Streptococcus pyogenes. Initial treatment is usually empiric. Although the most suitable oral treatment is likely cephalosporin, other options include β-lactamase inhibitor-penicillin combinations and penicillinase-resistant penicillins. In some cases, incision and drainage or debridement may be required.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 1.Lipsky B: Infectious problems of the foot in diabetic patients. In The Diabetic Foot, Sixth Edition. Edited by Bowker JH and Pfeifer MA. St. Louis: Mosby; 2001:467–480.Google Scholar
- 5.Reiber G: Epidemiology of foot ulcers and amputations in the diabetic foot. In The Diabetic Foot, Sixth Edition. Edited by Bowker JH and Pfeifer MA. St. Louis: Mosby; 2001:13–32.Google Scholar
- 6.Lipsky BA, Berendt AR, Deery HG, et al.: Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004, 39:885–910. Evidenced-based consensus statement from the Infectious Diseases Society of America. One of the most thorough documents ever written on the topic.PubMedCrossRefGoogle Scholar
- 19.Jego P, Resche S, Karacatsanis C, et al.: Erysipelas. A retrospective series of 92 patients in a department of internal medicine [in French]. Ann Med Interne (Paris) 2000, 151:3–9.Google Scholar
- 20.Joseph WS, Zgonis T, Roukis TS: A closer look at diabetic foot infections. Podiatry Today 2005, 18:56–66.Google Scholar
- 22.U.S Food and Drug Administration: Guidance for Industry. uncomplicated and complicated skin and skin structure infections—developing antimicrobial drugs for treatment. Draft guidance. http://www.fda.gov/cder/guidance/ 2566dft.pdf. Accessed August 24, 2005.Google Scholar
- 33.Dang CN, Prasad YD, Boulton AJ, Jude EB: Methicillinresistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med 2003, 20:159–161. A study that shows the increasing incidence of MRSA in the diabetic foot wound. Shows that the MRSA was eradicated without specific anti-MRSA therapy.PubMedCrossRefGoogle Scholar
- 37.International Working Group on the Diabetic Foot: International consensus on the diabetic foot [CD-ROM]. Brussels: International Diabetes Foundation; 2003.Google Scholar
- 38.Fridkin SK, Hageman JC, Morrison M, et al.: Methicillinresistant Staphylococcus aureus disease in three communities. N Engl J Med 2005, 352:1436–1444. An interesting discussion of the increasing prevalence of communityacquired MRSA. The study showed that patients not treated specifically for CA-MRSA did not suffer any adverse outcomes.PubMedCrossRefGoogle Scholar
- 44.American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media: Clinical practice guideline: Diagnosis and management of acute otitis media. Pediatrics 2004, 113:1451–1466.Google Scholar
- 45.American Academy of Pediatrics Subcommittee on Management of Sinusitis and Committee on Quality Improvement: Clinical practice guideline: management of sinusitis. Pediatrics 2001, 108:798–808.Google Scholar